We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
-16.57%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$2.32B
AUM Growth
-$327M
Cap. Flow
+$342M
Cap. Flow %
14.73%
Top 10 Hldgs %
50.61%
Holding
68
New
7
Increased
38
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$48.2M
2
ZBH icon
Zimmer Biomet
ZBH
+$31.6M
3
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$31.4M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$31.1M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$30.5M

Top Sells

Rank Stock Value
1
ACHN
Achillion Pharmaceuticals
ACHN
+$44.1M
2
ARVN icon
Arvinas
ARVN
+$15.2M
3
A icon
Agilent Technologies
A
+$12.8M
4
PODD icon
Insulet
PODD
+$11.6M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$8.74M

Sector Composition

Rank Sector Weight
1 Healthcare 94.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLSD
51
DELISTED
Clearside Biomedical
CLSD
$6.6M 0.28%
258,899
+8,892
+4% +$329K
TMDX icon
52
Transmedics
TMDX
$2.91B
$6.08M 0.26%
503,266
– –
ITMR
53
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$5.39M 0.23%
+457,218
New +$6.23M
INMD icon
54
InMode
INMD
$880M
$5.38M 0.23%
500,000
– –
LSACU
55
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
$5M 0.22%
+500,000
New +$4.95M
PHGE icon
56
BiomX
PHGE
$1.85M
$4.2M 0.18%
3,158
– –
ARGX icon
57
argenx
ARGX
$54.1B
$4.18M 0.18%
31,752
– –
PSNL icon
58
Personalis
PSNL
$1.51B
$2.06M 0.09%
255,000
– –
PROF
59
Profound Medical
PROF
$269M
$1.7M 0.07%
+174,193
New +$2.26M
FLGT icon
60
Fulgent Genetics
FLGT
$527M
$807K 0.03%
75,000
– –
MOTS
61
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$523K 0.02%
2,585
– –
TWST icon
62
Twist Bioscience
TWST
$7.25B
$469K 0.02%
+15,324
New +$412K
VRAY
63
DELISTED
ViewRay, Inc.
VRAY
$375K 0.02%
150,000
– –
PHGE.WS
64
DELISTED
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
$360K 0.02%
600,000
– –
A icon
65
Agilent Technologies
A
$41.2B
– –
-149,690
Closed -$12.8M
PODD icon
66
Insulet
PODD
$9.79B
– –
-67,725
Closed -$11.6M
ACHN
67
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-7,309,383
Closed -$44.1M
1 2
3

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

RTW Investments's Q1 2020 Portfolio in Review

As of Q1 2020, RTW Investments held 68 positions worth $2.32B, down 12% from $2.65B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

RTW Investments deployed $342M of net new capital in Q1 2020, opening 7 new positions and adding to 38 existing holdings. Its largest new stake was Global Blood Therapeutics, Inc.: 719,489 shares worth $36.8M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier.

On the sell side, the largest reduction was Arvinas, an estimated $15.2M trimmed.

  • RTW Investments's largest Q1 2020 buy was Global Blood Therapeutics, Inc.: 719,489 shares worth $36.8M.
  • RTW Investments added most to Zimmer Biomet in Q1 2020, an estimated $31.6M increase.
  • RTW Investments's biggest Q1 2020 reduction was Arvinas, cutting an estimated $15.2M.
  • RTW Investments fully exited Achillion Pharmaceuticals in Q1 2020, selling an estimated $44.1M.
  • RTW Investments's ten largest holdings make up 51% of its $2.32B portfolio in Q1 2020.
  • RTW Investments opened 7 new positions and closed 3 in Q1 2020.
  • RTW Investments's portfolio value fell 12% quarter-over-quarter to $2.32B.

Based on RTW Investments's 13F filing for Q1 2020, filed 15 May 2020.